Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC) Meeting Abstract
| Authors: | Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; Carter, D.; Seidman, A. D. |
| Abstract Title: | Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC) |
| Meeting Title: | 94th Annual Meeting of the American Association for Cancer Research (AACR) |
| Keywords: | clinical resistance |
| Journal Title: | Proceedings of the American Association for Cancer Research Annual Meeting |
| Volume: | 44 |
| Meeting Dates: | 2003 Jul 11-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 0197-016X |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2003-07-01 |
| Start Page: | 320 |
| End Page: | 320 |
| Language: | English |
| ACCESSION: | BCI:BCI200300475177 |
| PROVIDER: | biosis |
| Notes: | Meeting abstract: 1635 -- 94th Annual Meeting of the American Association for Cancer Research -- Washington, DC, USA -- July 11-14, 2003 -- Source: Biosis |
